Andrew Harrison

Andrew Harrison is CEO & General Partner at Section 32, where he invests in technology companies across the United States, with a focus on the West Coast and the San Francisco Bay Area. He invests at Seed, Series A, Series B, Series D, and other early stages. Section 32 raised a $525 million fund in October 2023. His sector coverage includes AI, health care, life sciences, infrastructure, enterprise services, cybersecurity, precision medicine, computational biology, climate tech, and quantum computing. He has invested in companies like Cohere, Scale AI, BigHat Biosciences, Forward Networks, and Sandbox AQ. Before Section 32, he held executive leadership roles at X (Google X) and served as Global Head of Business & Corporate Development and Ventures Lead at Verily (Google Life Sciences). Earlier, he was Managing Director and COO at Lapis Advisers, Managing Director and Head of Partnerships at Fintan Partners (acquired by Cantor Fitzgerald), Vice President and Portfolio Manager at Northwater Capital (acquired by Rithm Capital, NYSE:RITM), Senior Associate at RBC Venture Partners/DFJ-Primaxis, and started as an Analyst at RBC. Andrew holds an M.Eng. in Chemical and Biomolecular Engineering from Cornell University and a B.Eng. in Chemical and Biomolecular Engineering from McGill University, and he resides in Menlo Park, California.